Phase 2 Study of Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation Read more about Phase 2 Study of Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation
1% Chloroprocaine(PF) vs. Bupivacaine Spinals Read more about 1% Chloroprocaine(PF) vs. Bupivacaine Spinals
Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score Read more about Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
Thyroxine Treatment in Premature Infants With Intraventricular Hemorrhage Read more about Thyroxine Treatment in Premature Infants With Intraventricular Hemorrhage
Early Childhood Obesity Programming by Intrauterine Growth Restriction Read more about Early Childhood Obesity Programming by Intrauterine Growth Restriction
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671) Read more about Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
Medical Cannabis During Chemoradiation for Head and Neck Cancer Read more about Medical Cannabis During Chemoradiation for Head and Neck Cancer
Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis Read more about Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis Read more about Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Hydroxyurea Adherence for Personal Best in Sickle Cell Disease (HABIT): Efficacy Trial Read more about Hydroxyurea Adherence for Personal Best in Sickle Cell Disease (HABIT): Efficacy Trial